UF Health Maps Type 1 Diabetes Immune Attack Across 16 Million Pancreatic Cells
Updated
Updated · UF Health News · Jul 1
UF Health Maps Type 1 Diabetes Immune Attack Across 16 Million Pancreatic Cells
3 articles · Updated · UF Health News · Jul 1
Summary
A five-year UF Health study traced early Type 1 diabetes changes across 16 million pancreatic cells, giving researchers one of the clearest views yet of how the disease begins before diagnosis.
Pancreatic tissue from donors at multiple disease stages showed immune cells clustering near islets, where macrophages appeared to summon T cells that then attack insulin-producing beta cells.
The analysis also found beta-cell dysfunction starts very early, suggesting the autoimmune process is underway before symptoms emerge and potentially widening the window for intervention.
Imaging mass cytometry made the mapping possible by measuring nearly 100 protein markers at once—far beyond the three or four used historically—using tissue from UF-based nPOD, the field's largest donor repository.
Researchers said the findings could help identify therapeutic targets aimed at interrupting the immune attack earlier and altering Type 1 diabetes' course.
With the disease's first steps now mapped, can we develop a vaccine to prevent the autoimmune attack on the pancreas entirely?
If immune cells attack healthy pancreases, what is the initial 'false alarm' that triggers this fatal autoimmune response in the first place?
Four years after teplizumab's approval, are stem cell therapies finally ready to offer a drug-free cure for Type 1 diabetes?
Mapping the Immune Attack: How UF Health’s Pancreatic Gene Atlas is Transforming Type 1 Diabetes Diagnosis and Treatment
Overview
Recent advancements from the University of Florida Health Diabetes Institute have led to a significant breakthrough in understanding Type 1 diabetes. Researchers created a detailed map that uncovers hidden immune signals, providing crucial insights into how the immune system begins its attack on the pancreas. This comprehensive mapping effort sheds light on the earliest stages of the disease and offers a clearer picture of the immune system’s destructive actions. The study, supported by an extensive network, marks a major step forward in identifying how Type 1 diabetes develops and opens new possibilities for targeted therapies and prevention.